Publications by authors named "Carole Sable"

Claim this Profile
M
Meropenem-ANT3310, a unique β-lactam-β-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant .
Magdalena Zalacain, Pauline Achard, Agustina Llanos, Ian Morrissey, Stephen Hawser, Carole Sable

Antimicrob Agents Chemother· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher levels of Pseudomonas aeruginosa LasB elastase expression are associated with early-stage infection in cystic fibrosis patients.
Agustina Llanos, Pauline Achard, Justine Bousquet, Clarisse Lozano, Magdalena Zalacain, Carole Sable

Sci Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive .
Magdalena Zalacain, Clarisse Lozano, Agustina Llanos, Nicolas Sprynski, Thomas Valmont, Carole Sable

Antimicrob Agents Chemother· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing .
Shampa Das, Adam Johnson, Laura McEntee, Nicola Farrington, Adam Kirby, Carole Sable

Antimicrob Agents Chemother· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and development of first in class antifungal caspofungin (CANCIDAS®)--a case study.
James M Balkovec, David L Hughes, Prakash S Masurekar, Carole A Sable, Robert E Schwartz

Nat Prod Rep· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspofungin exposure-response relationships in adult patients with mucosal or invasive candidiasis.
Wendy Comisar, Peng Sun, Susan Li, Carole Sable, Michael Schwartz

Clin Pharmacol Drug Dev· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial.
Christopher Lucasti, Irinel Popescu, Mayakonda K Ramesh, Joy Lipka, Carole Sable

J Antimicrob Chemother· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study.
José A Vazquez, Luis Demetrio González Patzán, David Stricklin, Dipesh D Duttaroy, Zouheir Kreidly, Carole Sable

Curr Med Res Opin· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A web-based endpoint adjudication system for interim analyses in clinical trials.
Tracy L Nolen, Bill F Dimmick, Luis Ostrosky-Zeichner, Amy S Kendrick, Carole Sable

Clin Trials· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in antifungal therapy.
Carole A Sable, Kim M Strohmaier, Jeffrey A Chodakewitz

Annu Rev Med· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial.
Mark J DiNubile, Robert J Lupinacci, Kim M Strohmaier, Carole A Sable, Nicholas A Kartsonis

J Crit Care· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspofungin for the treatment of less common forms of invasive candidiasis.
Oliver A Cornely, Martin Lasso, Robert Betts, Nickolay Klimko, Jose Vazquez, Carole Sable

J Antimicrob Chemother· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis.
Johan Maertens, Axel Glasmacher, Raoul Herbrecht, Anne Thiebaut, Catherine Cordonnier, Carole Sable

Cancer· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients.
Robert Betts, Axel Glasmacher, Johan Maertens, Georg Maschmeyer, Jose A Vazquez, Carole Sable

Cancer· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents.
Thomas J Walsh, Peter C Adamson, Nita L Seibel, Patricia M Flynn, Michael N Neely, Carole A Sable

Antimicrob Agents Chemother· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome.
Nicholas Kartsonis, John Killar, Lori Mixson, Chao-Min Hoe, Carole Sable

Antimicrob Agents Chemother· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study.
Johan Maertens, Axel Glasmacher, Dominik Selleslag, Angela Ngai, Desmond Ryan, Carole Sable

Clin Infect Dis· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
Mark J DiNubile, Darcy Hille, Carole A Sable, Nicholas A Kartsonis

J Infect· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study.
Nicholas A Kartsonis, Alfred J Saah, C Joy Lipka, Arlene F Taylor, Carole A Sable

J Infect· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.
Johan Maertens, Issam Raad, George Petrikkos, Marc Boogaerts, Dominik Selleslag, Carole A Sable

Clin Infect Dis· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
Thomas J Walsh, Hedy Teppler, Gerald R Donowitz, Johan A Maertens, Lindsey R Baden, Carole A Sable

N Engl J Med· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study.
Nicholas A Kartsonis, Alfred Saah, C Joy Lipka, Arlene Taylor, Carole A Sable

J Antimicrob Chemother· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of caspofungin and amphotericin B for invasive candidiasis.
Jorge Mora-Duarte, Robert Betts, Coleman Rotstein, Arnaldo Lopes Colombo, Luis Thompson-Moya, Carole Sable

N Engl J Med· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole.
Nicholas Kartsonis, Mark J DiNubile, Ken Bartizal, Patricia Scott Hicks, Desmond Ryan, Carole A Sable

J Acquir Immune Defic Syndr· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis.
Alvaro Villanueva, Eduardo Gotuzzo, Eduardo G Arathoon, L Miguel Noriega, Nicholas A Kartsonis, Carole A Sable

Am J Med· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis